TSE:4461Chemicals
DKS (TSE:4461) Q3 EPS Surge Challenges Concerns Over Rich Valuation Multiples
DKS (TSE:4461) has just posted its Q3 2026 scorecard, reporting revenue of ¥22,598 million and basic EPS of ¥193.37, set against a trailing twelve month EPS figure of ¥489.08 supported by net income of ¥4,850 million. The company’s revenue has moved from ¥18,840 million in Q3 2025 to ¥18,984 million in Q4 2025, and then into the ¥18,565 million to ¥22,598 million range across the first three quarters of 2026. Over the same period, quarterly EPS shifted from ¥74.25 to ¥64.55 and then to...